A PROSPECTIVE COMPARATIVE STUDY OF INTRAVESICAL BACILLUS CALMETTE-GUERIN (BCG) THERAPY WITH THE TOKYO OR CONNAUGHT STRAINS FOR NON-MUSCLE INVASIVE BLADDER CANCER

被引：0
|
作者：
Sengiku, Atsushi
Ito, Masaaki
Miyazaki, Yu
Sawazaki, Harutake
Takahashi, Takeshi
Ogura, Keiji
机构：
来源：
JOURNAL OF UROLOGY | 2013年 / 189卷 / 04期
关键词：
D O I：
10.1016/j.juro.2013.02.2876
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
1786
引用
收藏
页码：E734 / E734
页数：1
相关论文
共 50 条
  • [21] Somatic features of response and relapse in non-muscle invasive bladder cancer treated with intravesical Bacillus Calmette-Guerin
    Muller, D. C.
    Bacon, J. V. W.
    Ritch, E.
    Dugas, S. G.
    Vandekerkhove, G.
    Annala, M.
    Black, P. C.
    Seifert, H.
    Bubendorf, L.
    Wyatt, A. W.
    Rentsch, C. A.
    EUROPEAN UROLOGY, 2021, 79 : S617 - S617
  • [22] Intravesical Bacillus Calmette-Guerin with interferon-alpha versus intravesical Bacillus Calmette-Guerin for treating non-muscle-invasive bladder cancer
    Shepherd, Andrew R. H.
    Shepherd, Emily
    Brook, Nicholas R.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2017, (03):
  • [23] RE-EVALUATION OF INTRAVESICAL GEMCITABINE IN BACILLUS CALMETTE-GUERIN UNRESPONSIVE NON-MUSCLE INVASIVE BLADDER CANCER
    Escano, Manuel R. De Jesus
    Vertosick, Emily
    Benfante, Nicole
    Lenis, Andrew T.
    Reisz, Peter A.
    Goh, Alvin
    Cha, Eugene
    Donahue, Timothy F.
    Bochner, Bernard H.
    Sjoberg, Dan
    Pietzak, Eugene J.
    JOURNAL OF UROLOGY, 2021, 206 : E299 - E299
  • [24] Single nucleotide polymorphisms as markers of bacillus Calmette-Guerin intravesical therapy response in non-muscle invasive bladder cancer.
    Alanee, Shaheen
    Hamilton, Robert James
    Joseph, Vijai
    Ostrovnaya, Irina
    Garcia-Grossman, Ilana Rebecca
    Gallagher, David J.
    Pendse, Deepa
    Regazzi, Ashley Marie
    Przybylo, Jennifer A.
    Gaudet, Mia
    Milowsky, Matthew I.
    Herr, Harry W.
    Offit, Kenneth
    Bajorin, Dean F.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [25] UTILIZATION PATTERNS OF INTRAVESICAL BACILLUS CALMETTE-GUERIN THERAPY FOR PATIENTS WITH HIGH-GRADE, NON-MUSCLE INVASIVE BLADDER CANCER
    Lenis, Andrew
    Litwin, Mark
    Saigal, Christopher
    Donin, Nicholas
    Lai, Julie
    Hanley, Jan
    Konety, Badrinath
    Chamie, Karim
    JOURNAL OF UROLOGY, 2016, 195 (04): : E8 - E8
  • [26] Treatment of non-muscle invasive bladder cancer with Bacillus Calmette-Guerin (BCG): Biological markers and simulation studies
    Kiselyov, Alex
    Bunimovich-Mendrazitsky, Svetlana
    Startsev, Vladimir
    BBA CLINICAL, 2015, 4 : 27 - 34
  • [27] Intravesical bacillus Calmette-Guerin(BCG)in treating non-muscle invasive bladder cancer——analysis of adverse effects and effectiveness of two strains of BCG(Danish 1331 and Moscow-Ⅰ)
    Yuvaraja B.Thyavihally
    Preetham Dev
    Santosh Waigankar
    Abhinav Pednekar
    Nevitha Athikari
    Abhijit Raut
    Archan Khandekar
    Naresh Badlani
    Ashishkumar Asari
    Asian Journal of Urology, 2022, (02) : 157 - 164
  • [28] Smoke load prognostic impact on bacillus Calmette-Guerin (BCG) treated non-muscle invasive bladder cancer
    Andrade, Danilo Leite
    Moretti, Tomas Bernardo Costa
    Neto, Wilmar Azal
    Benedetti, Julia
    Reis, Leonardo Oliveira
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2020, 52 (08) : 1471 - 1476
  • [29] INTRAVESICAL GEMCITABINE VERSUS INTRAVESICAL BACILLUS CALMETTE-GUERIN FOR THE TREATMENT OF NON-MUSCLE INVASIVE BLADDER CANCER: AN EVALUATION OF EFFICACY AND TOLERANCE
    Prasanna, T.
    Kuo, J. C.
    Hickie, M.
    Sim, B. W. C.
    Pranavan, G.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2014, 10 : 35 - 35
  • [30] Intravesical Gemcitabine versus Intravesical Bacillus Calmette-Guerin for the Treatment of Non-Muscle Invasive Bladder Cancer: An Evaluation of Efficacy and Toxicity
    Prasanna, Thiru
    Craft, Paul
    Balasingam, Gayathri
    Haxhimolla, Hodo
    Pranavan, Ganes
    FRONTIERS IN ONCOLOGY, 2017, 7
12345